Microfluidic devices for developing tissue scaffolds

摘要: This chapter begins by outlining the key hurdles that currently exist in terms of achieving directed tissue genesis, vitro and vivo, from available mature, progenitor stem cell sources. The then Sugiura et al., 2005 proceeds to describe how microfluidic device platforms can provide required insights overcome these clinical translation, including optimization soluble factor provision enhance expansion differentiation outcomes, impacts pore architecture surface engineering on scaffold colonization, biophysical needs cells when creating three dimensional artificial vascular pedicles for improved vascularization post-implantation.